DE69218461D1 - Pharmazeutische mischung mit antineoplastischer wirksamkeit - Google Patents

Pharmazeutische mischung mit antineoplastischer wirksamkeit

Info

Publication number
DE69218461D1
DE69218461D1 DE69218461T DE69218461T DE69218461D1 DE 69218461 D1 DE69218461 D1 DE 69218461D1 DE 69218461 T DE69218461 T DE 69218461T DE 69218461 T DE69218461 T DE 69218461T DE 69218461 D1 DE69218461 D1 DE 69218461D1
Authority
DE
Germany
Prior art keywords
pharmaceutical blend
antineoplastic
effectiveness
antineoplastic effectiveness
blend
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69218461T
Other languages
English (en)
Other versions
DE69218461T2 (de
Inventor
Mauro Esposito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per la Ricerca Sul Cancro
Original Assignee
Istituto Nazionale per la Ricerca Sul Cancro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per la Ricerca Sul Cancro filed Critical Istituto Nazionale per la Ricerca Sul Cancro
Application granted granted Critical
Publication of DE69218461D1 publication Critical patent/DE69218461D1/de
Publication of DE69218461T2 publication Critical patent/DE69218461T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69218461T 1991-05-16 1992-05-12 Pharmazeutische mischung mit antineoplastischer wirksamkeit Expired - Fee Related DE69218461T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI911344A IT1247937B (it) 1991-05-16 1991-05-16 Associazione farmaceutica ad attivita' antineoplastica
PCT/EP1992/001038 WO1992020353A1 (en) 1991-05-16 1992-05-12 Pharmaceutical combination having antineoplastic activity

Publications (2)

Publication Number Publication Date
DE69218461D1 true DE69218461D1 (de) 1997-04-24
DE69218461T2 DE69218461T2 (de) 1997-06-26

Family

ID=11359914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218461T Expired - Fee Related DE69218461T2 (de) 1991-05-16 1992-05-12 Pharmazeutische mischung mit antineoplastischer wirksamkeit

Country Status (5)

Country Link
EP (1) EP0639978B1 (de)
AU (1) AU1749092A (de)
DE (1) DE69218461T2 (de)
IT (1) IT1247937B (de)
WO (1) WO1992020353A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1102594E (pt) * 1998-08-05 2002-10-31 Aventis Pharma Sa Utilizacao de cloreto de sodio para reduzir a toxicidade gastrointestinal de derivados de camptotecina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy

Also Published As

Publication number Publication date
ITMI911344A1 (it) 1992-11-16
AU1749092A (en) 1992-12-30
EP0639978B1 (de) 1997-03-19
EP0639978A1 (de) 1995-03-01
ITMI911344A0 (it) 1991-05-16
DE69218461T2 (de) 1997-06-26
IT1247937B (it) 1995-01-05
WO1992020353A1 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
ATA129892A (de) Pharmazeutische zusammensetzung
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
NO20001227L (no) Medikamenter
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
ATE203400T1 (de) Pharmazeutische formulierungen
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922316A (fi) Farmaceutisk sammansaettning
DE3688532D1 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI981777A0 (fi) Farmaseuttinen ainekoostumus
DE69525148D1 (de) Pharmazeutische formulierung
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
DE68915203D1 (de) Pharmazeutische Mischungen.
DE69218461D1 (de) Pharmazeutische mischung mit antineoplastischer wirksamkeit
FI921786A (fi) Farmaceutisk foerening
DE58905160D1 (de) Pharmazeutische zubereitung.
DE19681529D2 (de) Pharmazeutische Darreichungsform
FI921785A (fi) Farmaceutisk foerening
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
DE69132145D1 (de) Peritoneal wirksame medikamente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee